Hepatology Review Time

Hepatology was up from 12.9 in 2023 to 15.8 in 2024 after the post-pandemic decline eased. The practical implication is that the journal's citation profile recovered while the editorial bar for liver-specific significance remained unchanged.

The official journal pages explain the submission workflow and peer-review model, but they do not give one stable median decision time that you should treat as a guarantee.

That means the honest way to use timing guidance is:

• use the official workflow to understand how the journal operates
• treat public timing reports as directional rather than exact
• focus on what usually creates delay rather than chasing one precise number

That matters at Hepatology because liver papers vary a lot in complexity. A clinical cohort, a transplant paper, and a mechanistic MASLD study can all move differently once the editors start matching reviewers.

The useful point is simple: the desk screen is usually fast, but the real cost sits in the full review and revision cycle.

The slower papers are usually the ones that:

• look liver-adjacent rather than clearly hepatology-first
• need reviewers with narrow subspecialty expertise
• trigger requests for stronger human validation or clearer translational framing
• come back from revision with partially addressed reviewer concerns

That is why authors often confuse delay with bad luck. Much of the timing friction is really a signal about how complete the paper looked on day one.

Quick rejection does not mean the science is poor. It often means the editors do not think the manuscript is strong enough or liver-specific enough for this room.

A slower review path does not mean you are close to acceptance either. It often means the paper had enough promise to justify a serious look, but not enough clarity to make the decision easy.

In other words, timing is often a proxy for editorial confidence, not just speed.

The better question is whether the manuscript is truly a Hepatology paper.

That is why the better next reads are:

• Hepatology acceptance rate
• Hepatology SJR and Scopus metrics
• Is Hepatology a good journal?
• Hepatology submission guide

If the paper has real liver-specific consequence and strong translational logic, the review timeline may be worth the wait. If the story still reads like general biology with a liver wrapper, the same timeline becomes a costly mismatch.

In our pre-submission review work on Hepatology-targeted manuscripts, three patterns most consistently predict slow review at Hepatology (American Association for the Study of Liver Diseases). Of manuscripts we screened in 2025 targeting Hepatology and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: Hepatology editors emphasize translational hepatology research with both mechanistic depth and clinical-application pathway.

Scope-fit ambiguity in the abstract. Hepatology editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (liver disease research with practice-changing or mechanistic-depth implications for working hepatologists). The named failure pattern: mechanism-only hepatology papers without clinical-translation pathway extend revision rounds. Check whether your abstract reads to Hepatology's scope →

Methods package incomplete for the journal's reviewer pool. Hepatology reviewers expect specific methodological detail. Clinical observational studies without mechanistic underpinning extend reviewer consultation. Check if your methods package is reviewer-complete →

Reference-list and clean-citation failure mode. Editorial team at Hepatology (American Association for the Study of Liver Diseases) screens reference lists for retracted-paper inclusion. Recent retractions in the Hepatology corpus we audit include 10.1002/hep.32547, 10.1002/hep.31829, and 10.1002/hep.32891. Citing any of these without a retraction-notice acknowledgment is an automatic desk-screen flag. Check whether your reference list is clean against Crossref + Retraction Watch →

Editorial detail (for desk-screen calibration). Editor-in-Chief: Hashem El-Serag (Baylor College of Medicine) leads Hepatology editorial decisions. Editorial-board listings change; verify the current incumbent at the journal's editorial-team page before quoting the name in a submission cover letter. Submission portal: https://mc.manuscriptcentral.com/hep. Manuscript constraints: 275-word abstract limit and 5,500-word main-text cap (Hepatology enforces during desk-screen). We reviewed each of these constraints against current journal author guidelines (accessed 2026-05-08); evidence basis for the patterns above includes both publicly documented author-guidelines and our internal anonymized submission corpus.

Manusights submission-corpus signal for Hepatology (American Association for the Study of Liver Diseases). Of the manuscripts our team screened before submission to Hepatology and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is Hepatology editors emphasize translational hepatology research with both mechanistic depth and clinical-application pathway. In our analysis of anonymized Hepatology-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear Hepatology's scope-fit threshold within the first week and those that get extended editorial-board consultation. The named editor responsible for top-line triage at Hepatology is Hashem El-Serag (Baylor College of Medicine). Recent retractions in the Hepatology corpus that should not appear in any submitted reference list: 10.1002/hep.32547, 10.1002/hep.31829.

Hepatology usually tells you relatively quickly whether the paper is in scope for serious consideration. After that, expect several weeks for review and potentially much longer if the revision demands real added validation.

So the useful takeaway is not one exact number. It is this: expect fast triage, expect a real review cycle if the paper clears the desk, and choose the journal based on liver-field fit rather than on the hope of a quick yes. A Hepatology submission framing check is the fastest way to pressure-test that before submission.

The review process at Hepatology follows a standard sequence, but the timing at each stage varies:

• Desk decision (1-3 weeks): The editor evaluates scope fit, novelty, and basic quality. This is the highest-risk point - many papers are rejected here without external review.

• Reviewer assignment (1-2 weeks): Finding qualified, available reviewers is often the biggest source of delay. Niche topics take longer.

• First reviewer reports (3-6 weeks): Reviewers typically have 2-3 weeks to respond, but many request extensions. Two reports is standard; three is common for interdisciplinary work.

• Editorial decision (1-2 weeks): The editor synthesizes reports and decides: accept, minor revision, major revision, or reject.

If your status hasn't changed in several weeks, the most common explanations are:

• Still "under review" after 6+ weeks: Likely waiting on a slow reviewer. Editors typically send reminders at 3-4 weeks.

• "Decision pending" for 2+ weeks: The editor may be waiting for a third reviewer, or handling a split decision between reviewers.

• Back to "under review" after revision: Revised manuscripts usually go back to the original reviewers, who may take 2-4 weeks.

A polite status inquiry is appropriate after 8 weeks with no update.

For career-critical deadlines (grant applications, job market cycles, tenure review):

• Submit at least 6 months before your hard deadline
• Have a backup journal identified before you submit
• If the timeline matters more than the venue, consider journals with faster review (check our review time comparison pages)

The Manusights Hepatology readiness scan. This guide tells you what Hepatology (American Association for the Study of Liver Diseases)'s editors look for in the first 1-2 weeks of triage. The review tells you whether YOUR paper passes that check before you submit. We have reviewed manuscripts targeting Hepatology (American Association for the Study of Liver Diseases) and peer venues; the named patterns below are the same ones Hashem El-Serag and outside reviewers flag at the desk-screen and first-review stages. documented review timeline of approximately 7-10 days for desk-screen. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.

Published Hepatology review-time medians mask real variation. Desk rejections at Hepatology (typically completing within the first 1-2 weeks) pull the median down; papers that pass desk-screen and enter full peer review experience longer waits than the median suggests. Seasonal effects matter: December submissions sit longer due to reviewer holiday availability, and September-October sees a backlog from the academic-year start at Hepatology (American Association for the Study of Liver Diseases). The published median does not include acceptance-to-publication production time.

A Hepatology desk-rejection risk check scores fit against the journal's editorial bar.